Skip to content

Clinical trials

Lung Diseases, Interstitial trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Phase: Not applicable Country / region: United States Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20111
20132
20141
20151
20162
20171
20181
20191
20202
20211
20222
20234
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting5
Terminated2
Unknown status2
Enrolling by invitation2
Not yet recruiting1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Duke University4
Johns Hopkins University3
VA Office of Research and Development3
University of Washington2
Columbia University1
Inova Health Care Services1
MGH Institute of Health Professions1
Mayo Clinic1
Medical University of South Carolina1
National Institutes of Health Clinical Center (CC)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial29
Pulmonary Disease, Chronic Obstructive11
Heart Failure6
Idiopathic Pulmonary Fibrosis6
Pulmonary Fibrosis6
Hypertension, Pulmonary4
Kidney Failure, Chronic4
Dementia3
Neoplasm Metastasis3
Chronic Disease2

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.